Monday, Sep. 13, 2010
The New Drug Crisis: Addiction
By Jeffrey Kluger
Update Appended: Sept. 17, 2010
It's not easy to find a mother who would look back fondly on the time her son had cancer. But Penny
(not her real name) does. Penny lives in Boston, and her son got sick when he was just 13. He
struggled with the disease for several years — through the battery of tests and the horror of the
diagnosis and, worst of all, through the pain that came from the treatment. For that last one, at least,
there was help — Oxycontin, a time-released opioid that works for up to 12 hours. It did the job, and
The brain loves Oxycontin — the way the drug lights up the limbic system, with cascading effects
through the ventral striatum, midbrain, amygdala, orbitofrontal cortex and prefrontal cortex, leaving
pure pleasure in its wake. What the brain loves, it learns to crave. That's especially so when the
alternative is the cruel pain of cancer therapy. By the time Penny's son was 17, his cancer was licked
— but his taste for Oxy wasn't. When his doctor quit prescribing him the stuff, the boy found the next
best — or next available — thing: heroin. Penny soon began spending her Monday nights at meetings
of the support group Learn to Cope, a Boston-based organization that counsels families of addicts,
particularly those hooked on opioids or heroin. (See the top 10 medical breakthroughs of 2009.)
"Penny told the group that she actually misses her son's cancer," says Joanne Peterson, the founder
of Learn to Cope. "When he had that, everyone was around. When he had that, he had support."
Penny and her son are not unique. Humans have never lacked for ways to get wasted. The natural
world is full of intoxicating leaves and fruits and fungi, and for centuries, science has added to the
pharmacopoeia. In the past two decades, that's been especially true. As the medical community has
become more attentive to acute and chronic pain, a bounty of new drugs has rolled off Big Pharma's
There was fentanyl, a synthetic opioid around since the 1960s that went into wide use as a treatment
for cancer pain in the 1990s. That was followed by Oxycodone, a short-acting drug for more routine
pain, and after that came Oxycontin, a 12-hour formulation of the same powerful pill. Finally came
hydrocodone, sold under numerous brand names, including Vicodin. Essentially the same opioid
mixed with acetaminophen, hydrocodone seemed like health food compared with its chemical
cousins, and it has been regulated accordingly. The government considers hydrocodone a Schedule
III drug — one with a "moderate or low" risk of dependency, as opposed to Schedule II's, which carry
a "severe" risk. Physicians must submit a written prescription for Schedule II drugs; for Schedule
III's, they just phone the pharmacy. (Schedule I substances are drugs like heroin that are never
prescribed.) For patients, that wealth of choices spelled danger. (See the most common hospital mishaps.)
"If someone is dying, addiction isn't a problem," says Dr. Jim Rathmell, chief of the division of pain
medicine at Massachusetts General Hospital. "But for prescribers, the distinction between a patient
who has three or four weeks to live and one who's 32 and has chronic back pain started to blur."
The result has hardly been a surprise. Since 1990, there has been a tenfold increase in prescriptions
for opioids in the U.S., according to the Centers for Disease Control and Prevention (CDC). In 2007,
3.7 million people filled 21 million legal prescriptions for opioid painkillers, and 5.2 million people
over the age of 12 reported using prescription painkillers nonmedically in the previous month,
according to a survey by the Substance Abuse and Mental Health Services Administration
(SAMHSA). From 2004 to '08, emergency-room visits for opioid misuse doubled. At the same time,
the drugs have become the stuff of pop culture, gaining cachet in the process. The fictitious Dr.
House and Nurse Jackie gobble them like gumdrops, as did the decidedly nonfictional Rush
Limbaugh and Heath Ledger. And, like Ledger, some users don't make it out alive.
In 1990 there were barely 6,000 deaths from accidental drug poisoning in the U.S. By 2007 that
number had nearly quintupled, to 27,658. In 15 states and the District of Columbia, unintentional
overdoses have, for the first time in modern memory, replaced motor-vehicle incidents as the leading
cause of accidental death; and in three more states it's close to a tie.
Watch TIME's video "Forget to Take Your Pills? Don't Worry, They'll Call You."
Health officials do not tease out which drug is responsible for every death, and it's not always
possible. "There may be lots of drugs on board," says Cathy Barber, director of the Injury Control
Research Center at the Harvard School of Public Health. "Is it the opioid that caused the death? Or is
it the combination of opioid, benzodiazepine and a cocktail the person had?" Still, most experts agree
that nothing but the exploding availability of opioids could be behind the exploding rate of death.
Contrary to stereotype, the people most at risk in this epidemic are not the usual pill-popping
suspects — the dorm rats and users of street drugs. Rather, they're so-called naive users in the 35-to-
64 age group — mostly baby boomers, with their aching bodies and their long romance with
pharmaceutical chemistry. "People with pain complaints get a 30-day prescription for Oxycontin,
and it's like a little opioid starter kit," says Barber.
The Food and Drug Administration (FDA) has, in its dilatory fashion, begun addressing the problem,
but it doesn't promise any action before next year — if then. That leaves millions of people
continuing to fill prescriptions, tens of thousands per year dying and patients in genuine pain
wondering when a needed medication will relieve their suffering — and when it could lead to
something worse. (See TIME's special report "How to Live 100 Years.")
The U.S.'s opiate jag began, like so many things, with the best of intentions. In the 1990s, the Joint
Commission on the Accreditation of Healthcare Organizations (JCAHO) — the accrediting body for
hospitals and other large care facilities — developed new policies to treat pain more proactively,
approaching it not just as an unfortunate side effect of illness but as a fifth vital sign, along with
temperature, heart rate, respiratory rate and blood pressure. As such, it would have to be routinely
assessed and treated as needed. "It was a compassionate change," says Barber. "Patient-advocacy
groups pushed hard for it." And, she points out, drug companies did too, since more-aggressive
treatment of pain meant more more-aggressive prescribing.
But the timing was problematic. The new JCAHO policy went into effect in 2000, which was not only
about the time the new opioids were hitting the market but also shortly after the Federal Trade
Commission began allowing direct-to-consumer drug advertising. When market, mission and
product converge this way, there's little question what will happen. And before long, patients were
not only being offered easy access to drugs but were actually having the medications pushed on
them. No tooth extraction was complete without a 30-day prescription for Vicodin. No ambulatory
surgery ended without a trip to the hospital pharmacy to pick up some Oxy. Worse, people with
chronic pain were getting prescriptions that could be renewed again and again. (Read "Curbing Drug-Company Abuses: Are Fines Enough?")
"For me, it started with lower-back pain," says Jason (not his real name), a carpenter in his late 50s.
Jason is a 90-day inpatient at the Hanley Center, a residential addiction facility in West Palm Beach,
Fla. "I went to my doctor, and he prescribed Oxycontin. After a little while, I was finishing a one-
month prescription in three weeks, then in two. I started complaining of more pain than I had so I
could get more Oxy, and finally I started buying it on the street. In a pharmacy, I paid $8 for 160
pills. On the street, I was paying $25 each."
Jason's demographic profile is typical of Hanley's — older, whiter and generally wealthier than
addicts of previous generations. And while some people do wind up buying on the street, many never
need to, thanks to the gray market that has sprouted up around opioid sales. As long as the drugs are
legal and real M.D.s are prescribing them, it's a simple matter to hang out a shingle and call yourself
a pain clinic. Pay-to-play patients are given prescriptions based on little more than their word that
they're in pain — sometimes backed up by self-evidently altered MRIs.
Says Evelyn (another pseudonym, and another baby boomer at Hanley), "When my physician refused
to prescribe me more pills, he sent me to a clinic. The doctor there didn't even ask me my name at
first. He wrote me a prescription while he was on the phone dealing with some court case he was
involved in. When you're well dressed and you have insurance, they don't think of you as an addict."
Read "Study Links Antidepressant Use and Miscarriage."
Florida is lousy with such pain-clinic pill mills, in part because of extremely loose oversight of the
people operating them. Until June, when Governor Charlie Crist signed a new law cracking down on
the operations, there was nothing to prevent felons from opening a clinic and hiring doctors to write
the prescriptions. Indeed, on the national ranking of practitioners dispensing Oxycodone, every doc
in the top 50 has a Sunshine State address.
"I've taken to calling the problem 'pharmageddon,'" says Dr. Barbara Krantz, Hanley's CEO and
medical director. "There are seven deaths per day in Florida from prescription-drug overdoses." The
state has also become a hub for opioid traffickers in the Southeast. (Read "Difficulties in Determining a Drug Overdose Death.")
What worries Krantz and other substance-abuse professionals is that an addiction scourge that is, for
now, hitting the boomer demographic hardest won't stay there and instead will gather greater
strength in the under-25 cohort. It's not just young cancer patients given a legal taste of Oxy who are
in danger in this group; it's everyone. "A parent comes home from the dentist with 30 doses of
Oxycontin and only takes a few," says Barber. "Then the pills are stored in the medicine chest, where
This is leading to a rise in the incidence of what's known as skittling, a social phenomenon with
deadly consequences. "Kids steal from their parents' medicine chests, go to a party and dump
everything into a bowl at the door," says Juan Harris, a Hanley drug counselor. "Anyone who comes
Killing the Buzz
For kids, education programs in schools help a little, at least in terms of informing them of the risks
associated with drugs. But such a rearguard action goes just so far, and a longer-term solution will
come only when the government increases its control over the legal dispensation of the most popular
pills. The first step would be better surveillance and tracking. An alphabet soup of agencies — from
the FDA to the CDC to SAMHSA to the National Institute of Drug Abuse — all have a hand in
monitoring prescription meds, but no single one is in charge. "You need Congress choosing an
agency and saying, 'This is your baby,'" says Barber.
In early 2009, the FDA announced that it was initiating a "risk-evaluation and mitigation strategy,"
contacting the opioid manufacturers and requiring them to participate in a study of how their meds
can continue to be made available while at the same time being better controlled. The regulations the
FDA is empowered to issue include requiring manufacturers to provide better information to
patients and doctors, requiring doctors to meet certain educational criteria before writing opioid
prescriptions and limiting the number of docs and pharmacies allowed to prescribe or dispense the
drugs. (See "The Year in Health 2009: From A to Z.")
"And with all that," warns Dr. John Jenkins, director of the FDA's Office of New Drugs, "we do still
have to make sure patients have access to drugs they need." Any regulations the FDA does impose
won't be announced until 2011 at the earliest and could take a year or more to roll out.
Other solutions don't face the same regulatory maze. The U.S. Drug Enforcement Administration
recently announced a straightforward idea to reduce misuse: a drug take-back day on Sept. 25, 2010,
when patients can safely dispose of unwanted prescription drugs at 3,400 government-sponsored
sites around the country. An electronic database of all pharmacies across the country could also help
catch patients and doctors who are gaming the system, particularly those who hopscotch across state
lines. Doctors need to be less cavalier about prescribing drugs and stingier with the amount they do
allow. They could also do a better job of assessing patients for addictive histories and requiring urine
tests if they suspect a problem. If the patients don't want to comply, they don't have to — but they
Insurers — the bad guys in so many policy debates — can do a lot of good, keeping better track of the
number and types of controlled substances policyholders are receiving. Big Pharma must help as
well, and that means climbing down off the opioid gravy train and working harder to develop more
nonaddictive painkillers — even if it means fewer sales and lower profits. At least one company, New
Jersey–based King Pharmaceuticals, is seeking a solution. According to a recent review article in the
the company is experimenting with abuse-deterrents built directly into pills. One
technique involves including pellets coated with a chemical called naltrexone — which neutralizes the
effects of opioids — in the pill. The pellets remain intact and pass through the body if the drug is
taken as intended. If the pill is crushed, however — a trick addicts use to produce a faster, more
powerful kick — the naltrexone is released, killing the high.
Until then, it's up to responsible doctors and cautious patients to keep the epidemic in check. That,
certainly, is not easy. "When drug addicts or alcoholics ask us if they can ever use substances in
moderation, we tell them no," says Krantz. "Once your brain becomes a pickle, it can't go back to
being a cucumber." Too many Americans are pickled already. The time to help them — and protect
This is an updated version of a story that originally appeared in the Sept. 13, 2010, issue of TIME.
Click to Print
Find this article at:
What Your Pharmacist Should Know adapted from “The Fibromyalgia Advocate” This information may be freely copied and distributed only if unaltered, with complete original content including: © Devin Starlanyl, 2008. Each of us with fibromyalgia (FM) and Chronic Myofascial Pain (CMP) needs a trustworthy pharmacist to coordinate our medications and keep us informed. New medications are com
The Management of Premature Ejaculation: A Patient’s Guide How does ejaculation occur? Ejaculation, control ed by the central nervous system, happens when friction on the genitalia and other forms of sexual stimulation provide impulses that are sent up the spinal cord and into the brain. Ejaculation has two phases: PHase i: emission The vas deferens (the tubes that store and transport